Artelo Biosciences Valuation

ARTL Stock  USD 1.10  0.01  0.90%   
Today, the firm appears to be overvalued. Artelo Biosciences shows a prevailing Real Value of $0.95 per share. The current price of the firm is $1.1. Our model approximates the value of Artelo Biosciences from analyzing the firm fundamentals such as Current Valuation of (1.16 M), shares owned by insiders of 0.82 %, and Return On Equity of -0.89 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
1.10
Please note that Artelo Biosciences' price fluctuation is extremely dangerous at this time. Calculation of the real value of Artelo Biosciences is based on 3 months time horizon. Increasing Artelo Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Artelo stock is determined by what a typical buyer is willing to pay for full or partial control of Artelo Biosciences. Since Artelo Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Artelo Stock. However, Artelo Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.1 Real  0.95 Hype  1.1 Naive  1.12
The intrinsic value of Artelo Biosciences' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Artelo Biosciences' stock price.
0.95
Real Value
5.94
Upside
Estimating the potential upside or downside of Artelo Biosciences helps investors to forecast how Artelo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Artelo Biosciences more accurately as focusing exclusively on Artelo Biosciences' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.051.151.25
Details
Hype
Prediction
LowEstimatedHigh
0.061.106.09
Details
Naive
Forecast
LowNext ValueHigh
0.021.126.11
Details

Artelo Biosciences Total Value Analysis

Artelo Biosciences is presently anticipated to have valuation of (1.16 M) with market capitalization of 3.58 M, debt of 1.29 M, and cash on hands of 21.32 M. The negative valuation of Artelo Biosciences may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Artelo Biosciences fundamentals.
  Takeover PriceMarket CapDebt ObligationsCash
(1.16 M)
3.58 M
1.29 M
21.32 M

Artelo Biosciences Asset Utilization

One of the ways to look at asset utilization of Artelo is to check how much profit was generated for every dollar of assets it reports. Artelo Biosciences shows a negative utilization of assets of -0.54 percent, losing $0.005433 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Artelo Biosciences shows how discouraging it operates for each dollar spent on its assets.

Artelo Biosciences Ownership Allocation

Almost 98.48 percent of Artelo Biosciences outstanding shares are held by general public with 0.82 (percent) owned by insiders and only 0.7 % by other corporate entities.

Artelo Biosciences Profitability Analysis

Net Loss for the year was (9.29 M) with profit before overhead, payroll, taxes, and interest of 0.

About Artelo Biosciences Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Artelo Biosciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Artelo Biosciences based exclusively on its fundamental and basic technical indicators. By analyzing Artelo Biosciences's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Artelo Biosciences's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Artelo Biosciences. We calculate exposure to Artelo Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Artelo Biosciences's related companies.
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California. Artelo Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.

Artelo Biosciences Growth Indicators

Investing in growth stocks can be very risky. If the company such as Artelo Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding3.2 M
When determining whether Artelo Biosciences is a strong investment it is important to analyze Artelo Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Artelo Biosciences' future performance. For an informed investment choice regarding Artelo Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artelo Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Business Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Artelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.